Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients
In: Clinical infectious diseases, Jg. 27 (1998), Heft 3, S. 573-581
Online
academicJournal
- print, 56 ref
Zugriff:
Oral ganciclovir prophylaxis decreases the incidence of cytomegalovirus (CMV) disease among persons infected with the human immunodeficiency virus (HIV), but universal prophylaxis is not cost-effective. We evaluated urine and peripheral blood mononuclear cell cultures, a qualitative and quantitative antigenemia assay, and a commercially available CMV DNA hybridization assay for their ability to predict CMV disease in 138 HIV-infected patients. During a median follow-up of 10 months, 23 patients (17%) developed CMV disease. The sensitivity, specificity, positive predictive value, negative predictive value, and mean lead times for the antigenemia assay (with use of a threshold of 8 positive cells per 105 peripheral blood mononuclear cells as a positive) were 74%, 91%, 63%, 95%, and 95 days, respectively. Corresponding figures for the DNA hybridization assay were 91%, 64%, 34%, 97%, and 152 days. These assays can identify patients at increased risk of CMV disease and should allow a strategy of preemptive therapy to be tested.
Titel: |
Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients
|
---|---|
Autor/in / Beteiligte Person: | WALMSLEY, S ; O'ROURKE, K ; MORTIMER, C ; RACHLIS, A ; FONG, I ; MAZZULLI, T |
Link: | |
Zeitschrift: | Clinical infectious diseases, Jg. 27 (1998), Heft 3, S. 573-581 |
Veröffentlichung: | Chicago, IL: University of Chicago Press, 1998 |
Medientyp: | academicJournal |
Umfang: | print, 56 ref |
ISSN: | 1058-4838 (print) |
Schlagwort: |
|
Sonstiges: |
|